Literature DB >> 11405075

Accumulation of latent transforming growth factor-beta binding protein-1 and TGF beta 1 in extracellular matrix of filtering bleb and of cultured human subconjunctival fibroblasts.

S Saika1, O Yamanaka, Y Baba, Y Kawashima, K Shirai, T Miyamoto, Y Okada, Y Ohnishi, A Ooshima.   

Abstract

PURPOSE: To examine immunohistochemically whether extracellular matrix (ECM) of the filtering bleb and of cultured human subconjunctival fibroblasts contains latent TGF beta binding protein-1 (LTBP-1) and TGF beta.
METHODS: An enucleated human eye that had undergone trabeculectomy and cultured human subconjunctival fibroblasts were processed for light microscopic immunohistochemistry. Antibodies against LTBP-1, collagen types, fibrillin-1 and TGF beta s were used. TGF beta 1 was located by detecting beta 1-latency associated peptide (LAP).
RESULTS: LTBP-1, beta 1-LAP and fibrillin-1 were all located in the subepithelial ECM as well as in the basal epithelial cells of the conjunctiva over the filtering bleb. TGF beta 2 and beta 3 were immunolocated to epithelium and/or fibroblasts/keratocytes. ECM deposited in confluent fibroblast cultures was positive for beta 1-LAP, LTBP-1 and fibrillin-1, whereas sparse cells were negative.
CONCLUSIONS: LTBP-1, beta 1-LAP and fibrillin-1 are co-localized to the ECM of the filtering bleb and of cultured conjunctival fibroblasts. Both conjunctival epithelium and fibroblasts are considered to be the source of TGF beta in healing bleb. ECM secreted by in vivo and in vitro subconjunctival fibroblasts may works as a scavenger or repository of TGF beta.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11405075     DOI: 10.1007/s004170100275

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  14 in total

Review 1.  Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.

Authors:  A Guzman-Aranguez; P Loma; J Pintor
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

2.  MicroRNA-29 mediates TGFβ1-induced extracellular matrix synthesis by targeting wnt/β-catenin pathway in human orbital fibroblasts.

Authors:  Jia Tan; Bo-Ding Tong; Yu-Jie Wu; Wei Xiong
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

3.  Effects of octreotide acetate and amniotic membrane on wound healing in experimental glaucoma surgery.

Authors:  Tamer Demir; Burak Turgut; Ulku Celiker; Ibrahim Ozercan; Fatih Ulas; Nuray Akyol
Journal:  Doc Ophthalmol       Date:  2003-09       Impact factor: 2.379

4.  Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitor.

Authors:  Jennifer Sapitro; Jeffrey J Dunmire; Sarah E Scott; Vijay Sutariya; Werner J Geldenhuys; Michael Hewit; Beatrice Y J T Yue; Hiroshi Nakamura
Journal:  Mol Vis       Date:  2010-09-16       Impact factor: 2.367

5.  Connective tissue growth factor modulates extracellular matrix production in human subconjunctival fibroblasts and their proliferation and migration in vitro.

Authors:  Osamu Yamanaka; Shizuya Saika; Kazuo Ikeda; Ken-Ichi Miyazaki; Ai Kitano; Yoshitaka Ohnishi
Journal:  Jpn J Ophthalmol       Date:  2008-03-28       Impact factor: 2.447

6.  A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor beta (TGFbeta) ligands.

Authors:  Kelly L Walton; Yogeshwar Makanji; Matthew C Wilce; Karen L Chan; David M Robertson; Craig A Harrison
Journal:  J Biol Chem       Date:  2009-02-03       Impact factor: 5.157

7.  Collecting and deactivating TGF-β1 hydrogel for anti-scarring therapy in post-glaucoma filtration surgery.

Authors:  Ruiqi Wang; Boyang Chen; Haiying Wei; Wei Yan; Yuping Wu; Cao Wang; Bosong Zhang; Fengzhen Liu; Hui Tian; Xiongbiao Chen; Weiming Tian
Journal:  Mater Today Bio       Date:  2022-04-18

8.  In vitro analyses of the anti-fibrotic effect of SPARC silencing in human Tenon's fibroblasts: comparisons with mitomycin C.

Authors:  Li-Fong Seet; Roseline Su; Li Zhen Toh; Tina T Wong
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

9.  Topical infliximab for the suppression of wound healing following experimental glaucoma filtration surgery.

Authors:  Burak Turgut; Kenan Eren; Mehmet Mustafa Akın; Tamer Demir; Sabiha Kobat
Journal:  Drug Des Devel Ther       Date:  2014-05-02       Impact factor: 4.162

10.  Localization of TGF-beta type II receptor and ED-A fibronectin in normal conjunctiva and failed filtering blebs.

Authors:  Tobias Meyer-Ter-Vehn; Franz Grehn; Günther Schlunck
Journal:  Mol Vis       Date:  2008-01-25       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.